Data protection Impressum

Investment

Asterigo has opened a new office in Geneva to better support its Swiss customers and strengthen its local presence.

Asterigo opens new Geneva office to further support Swiss customers

16 July 2024

With a performance of 138.4% of the EU average, Switzerland is at the forefront of fostering innovation, displaying particular strengths in education-related indicators, scientific publications, and environment-related technologies.

Switzerland continues to lead the European Innovation Scoreboard in 2024

10 July 2024

Global demand for biologics is at an all-time high, and Western Switzerland is positioning itself as a key player in meeting that demand.

Biomanufacturing in Western Switzerland

The canton of Fribourg is investing nearly CHF 500 million in the development of the AgriCo Campus to strengthen its position as a leader in the agri-food industry.

Nearly CHF 500 million invested in Fribourg’s pioneering AgriCo campus

8 July 2024

Forestay Capital, a Geneva-based venture capital firm specializing in growth-stage investments, has closed its second fund at USD 220 million, backed by major European and Swiss family offices.

Geneva VC Forestay Capital secures USD 220 million towards Enterprise AI and SaaS

8 July 2024

Watertracks, a French start-up founded in 2016 and based in Occitanie, has opened its first Swiss subsidiary in the canton of Fribourg.

Watertracks chooses Fribourg for its first Swiss subsidiary

3 July 2024

WNG, a Swiss digital strategy firm, and Antadis, a French e-commerce specialist, have formed a joint venture to bring advanced e-commerce solutions to the Swiss market.

WNG and Antadis join forces to elevate Swiss e-commerce

10 June 2024

Trufflepig Forensics GmbH, a Bavarian-founded ethical hacking firm, has announced the establishment of its new subsidiary, Trufflepig IT-Forensics Suisse, in Fribourg.

Trufflepig Forensics expands to Fribourg to strengthen cybersecurity in the DACH region

6 May 2024

The latest edition of the Swiss Biotech Report underscores the continued growth and resilience of Switzerland’s biotech sector, attributing success to strong international collaborations and innovative advancements that promise to reshape healthcare worldwide.

The Swiss biotech industry: reliable partners beyond borders

23 April 2024

Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.

Symbio invests CHF 12 million in new research facility in Corminboeuf

16 April 2024

1 2 3 4 5 6 7 8 9 10 … 20